The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.
PTSD
1 other identifier
observational
18
1 country
1
Brief Summary
We hypothesize that prevention of Sleep Disordered Breathing among PTSD patients with nasal CPAP will result improve their anxiety, insomnia and alcohol craving (among those who use alcohol to control their symptoms).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 13, 2012
CompletedFirst Posted
Study publicly available on registry
January 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedSeptember 25, 2014
September 1, 2014
4.4 years
January 13, 2012
September 23, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The Effect of nasal Continuous Positive Airway Pressure (nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.
A comparison of the effectiveness of six weeks of nasal CPAP plus usual care to usual care alone at decreasing the symptoms of PTSD (anxiety, insomnia and alcohol craving) among veterans with PTSD and SDB
six weeks of nasal CPAP
Secondary Outcomes (1)
The Effect of nasal Continuous Positive Airway Pressure (nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.
6 weeks of nasal CPAP
Interventions
6 weeks of CPAP
Eligibility Criteria
veterans admitted to PTSD unit at Northport VAMC
You may qualify if:
- A. Admitted to PTSD unit at NVAMC and will remain in the unit for at least 12 weeks after initiation of study participation.
- B. Found to have SDB by polysomnography
You may not qualify if:
- Impaired Decision-Making Capacity, as determined by treating psychiatrist.
- No sleep disordered breathing found by polysomnography
- Unable/unwilling to use the nasal CPAP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PTSD unit at Northport VAMC
Northport, New York, 11768, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Amin, MD
Northport VAMC
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Physician
Study Record Dates
First Submitted
January 13, 2012
First Posted
January 19, 2012
Study Start
March 1, 2010
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
September 25, 2014
Record last verified: 2014-09